Sept. 16, 2025 - ITM Isotope Technologies Munich SE (ITM) plans to unveil dosimetry data from its recent Phase 3 COMPETE trial in an oral presentation at the European Association of Nuclear Medicine (EANM) congress in October in Barcelona, Spain. The company will also host a satellite symposium on targeted theranostics for the treatment of neuroendocrine tumors (NETs) and “Meet the Expert” sessions at its conference booth. 

Sept. 15, 2025 — Cook Medical and Siemens Healthineers have announced a strategic commercial partnership aimed at setting a new standard for interventional medicine. The collaboration combines the power of Siemens Healthineers real-time magnetic resonance imaging with Cook Medical's deep interventional procedure expertise, along with new medical devices developed by Cook specifically for the MRI environment.

Sept. 11, 2025 — A new PET tracer can provide insights into how spinal cord injuries affect not only the spinal cord, but also the brain, according to new research published in The Journal of Nuclear Medicine. By identifying synapse loss, the PET approach provides molecularly unique and complementary information to other structural imaging methods, offering a promising objective metric to evaluate novel therapeutics for spinal cord injuries.

Sept. 11, 2025 — Naitive Technologies, a medical technology company developing AI-driven software to reimagine orthopedic care, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship product, OsteoSight. OsteoSight enables opportunistic assessment of bone mineral density (BMD) using standard X-rays acquired to investigate other clinical concerns, such as pain associated with arthritis or a fall.

Sept. 10, 2025 —GE HealthCare announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease to meet the growing demand for MRI in personalized treatment planning.